STX-0712

Asset

Depletes disease-driving CCR2-positive malignant monocytes and bone marrow progenitors.

Stage
Phase 1
Modality
Other
Target
CCR2
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets